| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Director
1 company
Wendel Bruce is a Director at GT Biopharma, Inc.. Recent SEC Form 4 filings include 3 buys and 0 sells.
Estimated insider holdings value: $132K based on current market prices.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Dec 22, 2020 | GTBP Gt Biopharma, Inc. | Director | Buy | 5,083 | $5.17 | $26,298.83 | +64.3% |